At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients: an Open-Labelled Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Chlorhexidine gluconate and Potassium permanganate for Nosocomial Pneumonia and 3 related conditions. Completed, enrolled 512 participants across 1 site.
Detailed Summary
Oropharyngeal bacteria play an important role in the pathogenesis of nosocomial pneumonia in critically ill patients. Oral cleansing with chlorhexidine has been shown to decrease incidence of pneumonia in patients undergoing open heart surgery. Its role in critically ill general ICU patients is not yet proven. The present study proposes to study the effectiveness of twice-daily oral cleansing with 0.2% chlorhexidine solution on the incidence of nosocomial pneumonia in ICU patients admitted to a single intensive care unit of an Indian public hospital
Study Details
Timeline
Interventions
Twice-daily oropharyngeal cleansing with 0.2% Chlorhexidine gluconate
Twice-daily oropharyngeal cleansing with 0.01% Potassium permanganate